Dr Elizabeth Bernard

  • MBBS Honours FRACP, FAANMS
  • Nuclear Medicine Physician

Overview

Other clinical interests

SIRT therapy

Research interests

  • Functional imaging to guide radionuclide therapy.
  • Selective internal radiation therapy for primary and secondary hepatic malignancies

Publications and affiliations

  • Chan DL, Pavlakis N, Schembri GP, Bernard EJ, Hsiao E, Hayes A, Barnes T, Diakos C, Khasraw M, Samra J, Eslick E, Roach PJ, Engel  A, Clarke SJ, Bailey DL. Dual Somatostatin Receptor/FDG PET/CT  Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance. Theranostics 7. 2017/04/25 ed:1149-1158 (2017)
  • Willowson KP, Hayes AR, Chan DLH, Tapner M, Bernard EJ, Maher R, Pavlakis N, Clarke SJ, Bailey DL. Clinical and imaging based prognostic factors in radioembolisation of liver metastases from colorectal cancer: a retrospective exploratory analysis. EJNMMI, Res 7. 2017/05/26 ed:46 (2017)
  • Willowson KP, Bernard EJ, Maher R, Clarke SJ, Bailey DL. Changing Therapeutic Paradigms: Predicting mCRC Lesion Response to Selective Internal Radionuclide Therapy (SIRT) based
    on Critical Absorbed Dose Thresholds: A Case Study. Asia Oceania J Nucl Med Biol 5:66-69 (2017)
  • Willowson KP, Eslick E, Ryu H, Poon A, Bernard EJ, Bailey DL. Feasibility and accuracy of single time point imaging for renal dosimetry following (177)Lu-DOTATATE (‘Lutate’) therapy. EJNMMI Phys 5. 2018/12/21 ed:33 (2018)
  • Chan DL, Bernard E, Schembri G, Roach P, Johnson M, Pavlakis N, Clarke SJ, Bailey D. High metabolic tumour volume on FDG PET predicts poor survival from neuroendocrine neoplasms. Neuroendocrinology. 2019/11/12 ed (2019)
  • Willowson KP, Schembri GP, Bernard EJ, Chan DL, Bailey DL. Quantifying the effects of absorbed dose from radioembolisation on healthy liver function with [(99m)Tc]TcMebrofenin. Eur J Nucl Med Mol Imaging. 2020/01/21 ed (2020)

Professional memberships

  • FRACP
  • AANMS